Deregulation of MUC5AC is implicated in a number of nonneoplastic diseases, including cystic fibrosis,19 chronic obstructive pulmonary disease,20 asthma,21 inflammatory bowel disease,22 and a variety of cancers.23 Here, MUC5AC is linked to cystic fibrosis.